Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research databaseBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b3999 (Published 15 October 2009) Cite this as: BMJ 2009;339:b3999
- Michael Moore, senior lecturer1,
- Ho Ming Yuen, medical statistician2,
- Nick Dunn, director of GP teaching3,
- Mark A Mullee, director, research design service south central2,
- Joe Maskell, data manager2,
- Tony Kendrick, professor of primary medical care1
- 1University of Southampton, Aldermoor Health Centre, Southampton SO16 5ST
- 2Public Health Sciences and Medical Statistics, University of Southampton, Southampton SO16 6YD
- 3Division of Medical Education, School of Medicine, University of Southampton, Southampton SO16 7PX
- Correspondence to: Michael Moore
- Accepted 14 July 2009
Objective To explore the reasons behind the recent increase in antidepressant prescribing in the United Kingdom.
Design Detailed retrospective analysis of data on general practitioner consultations and antidepressant prescribing.
Data source Data were obtained from the general practice research database, which contains linked anonymised records of over 3 million patients registered in the UK. Data were extracted for all new incident cases of depression between 1993 and 2005.
Review methods Detailed analysis of general practitioner consultations and antidepressant prescribing was restricted to 170 practices that were contributing data for the full duration of the study.
Results In total, 189 851 people within the general practice research database experienced their first episode of depression between 1993 and 2005, of whom 150 825 (79.4%) received a prescription for antidepressants in the first year of diagnosis. This proportion remained stable across all the years examined. The incidence of new cases of depression rose in young women but fell slightly in other groups such that overall incidence increased then declined slightly (men: 7.83 cases per 1000 patient years in 1993 to 5.97 in 2005, women: 15.83 cases per 1000 patient years in 1993 to 10.06 in 2005). Antidepressant prescribing nearly doubled during the study period—the average number of prescriptions issued per patient increased from 2.8 in 1993 to 5.6 in 2004. The majority of antidepressant prescriptions were given as long term treatment or as intermittent treatment to patients with multiple episodes of depression.
Conclusions The rise in antidepressant prescribing is mainly explained by small changes in the proportion of patients receiving long term treatment. Previous clinical guidelines have focused on antidepressant initiation and appropriate targeting of antidepressants. To address the costly rise in antidepressant prescribing, future research and guidance needs to concentrate on appropriate long term prescribing for depression and regular review of medication.
We thank Peter Smith for statistical advice and support.
Contributors: MM and TK led the data interpretation and MM the writing of the paper and is the guarantor. TK and ND conceived the original research concept and obtained the dataset from the general practitioner research database. HMY, MAM, and JM undertook the data synthesis and analysis. All contributors assisted with the journal article.
Competing interests: The data were purchased from the GPRD by the University of Southampton, which employs all the researchers. MM and TK have received research funding from Lilly, Lundbeck, Servier, and Wyeth Pharmaceuticals. The remaining authors declare no competing interests.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.